Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

The Relationship Between ImmuKnow Value of Cellular Immune Function and Peripheral White Blood Cells Count and T-lymphocyte after Liver Transplantation

Correlation research on the early stage white blood cell count and ATP value in CD4+T cell by ImmuKnow method after liver transplantation

Application of immune cell functional assay in monitoring immune status in renal transplant recipients

Relation of ATP Content in CD4+ T Cells to Acute Rejection after Liver Transplantation

A Quantitative Assessment Model of T-Cell Immune Function for Predicting Risks of Infection and Rejection During the Early Stage after Liver Transplantation

Relationship between the ATP level in CD4+ T lymphocyte and recurrence of hepatocellular carcinoma after liver transplantation

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Navigating Immune Cell Immunometabolism after Liver Transplantation

An Immune Function Assay Predicts Post-Transplant Recurrence in Patients with Hepatocellular Carcinoma

Peripheral Blood CD 4 + Cell ATP Activity Measurement to Predict HCC Recurrence Post‐ DCD Liver Transplant

A High Frequency of CD8+CD28- T-suppressor Cells Contributes to Maintaining Stable Graft Function and Reducing Immunosuppressant Dosage after Liver Transplantation

Application of ImmuKnow immune cell function assay in monitoring of immune function after renal transplantation

Individualized Management of Immunosuppressants in Liver Transplant Recipients by Using a Novel Immune Score System

PP-062 Role of the Cellular Immunology Function Test in Preventing and Treating the Fungal Infection Following Liver Transplantation

Diagnosis Value of the Expression of CD44 in Acute Rejection after Human Liver Transplantation

The Relationship Between Adenosine Triphosphate Within CD4+ T Lymphocytes and Acute Rejection after Liver Transplantation

Study on reference values of T-lymphocyte subsets and NK cell percentage after renal transplant operation

Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation

Delayed introduction of immunosuppressive regimens in critically ill patients after liver transplantation

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

THE CHANGE OFT-LYMPHOCYTE SUBSETS IN ACUTE REJECTION IN RECIPIENTS OF LIVER TRANSPLANTATION